Alpharma Rejects King's Advances - Forbes

by Pain management @ Thu, 28 Aug 2008 02:00:05 -0500
Alpharma doesn't think that King Pharmaceuticals is playing fair and therefore has said "No, No, No" to the company's advances. The Bristol, Tenn.-based pharma announced on Friday that it has offered Alpharma (nyse: ALO - news - people ) a $33.00 ...
  • Recent posts